CA2005502A1 - Analogues de la somatotrophine - Google Patents
Analogues de la somatotrophineInfo
- Publication number
- CA2005502A1 CA2005502A1 CA 2005502 CA2005502A CA2005502A1 CA 2005502 A1 CA2005502 A1 CA 2005502A1 CA 2005502 CA2005502 CA 2005502 CA 2005502 A CA2005502 A CA 2005502A CA 2005502 A1 CA2005502 A1 CA 2005502A1
- Authority
- CA
- Canada
- Prior art keywords
- analogs
- somatotropin
- somatotropin analogs
- lactation
- serine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 108010006025 bovine growth hormone Proteins 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- -1 cysteine amino acids Chemical group 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30473389A | 1989-01-31 | 1989-01-31 | |
| US07/304,733 | 1989-01-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2005502A1 true CA2005502A1 (fr) | 1990-07-31 |
| CA2005502C CA2005502C (fr) | 2001-06-05 |
Family
ID=23177749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2005502 Expired - Fee Related CA2005502C (fr) | 1989-01-31 | 1989-12-15 | Analogues de la somatotrophine |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0456642A1 (fr) |
| JP (1) | JP3207416B2 (fr) |
| AU (1) | AU620673B2 (fr) |
| CA (1) | CA2005502C (fr) |
| DK (1) | DK140491D0 (fr) |
| WO (1) | WO1990008823A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE198353T1 (de) * | 1988-08-24 | 2001-01-15 | American Cyanamid Co | Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung |
| US5534617A (en) * | 1988-10-28 | 1996-07-09 | Genentech, Inc. | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
| US5688666A (en) * | 1988-10-28 | 1997-11-18 | Genentech, Inc. | Growth hormone variants with altered binding properties |
| US5849694A (en) * | 1990-07-16 | 1998-12-15 | Synenki; Richard M. | Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof |
| DE69638117D1 (de) * | 1995-09-21 | 2010-03-04 | Genentech Inc | Varianten des menschlichen Wachstumshormons |
| US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7795210B2 (en) | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
| US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| US8008252B2 (en) | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
| MXPA05009726A (es) | 2003-03-14 | 2005-11-04 | Neose Technologies Inc | Polimeros ramificados, solubles en agua y sus conjugados. |
| NZ542586A (en) | 2003-04-09 | 2009-11-27 | Biogenerix Ag | Method of forming a covalent conjugate between a G-CSF peptide and PEG |
| ATE540055T1 (de) | 2003-05-09 | 2012-01-15 | Biogenerix Ag | Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons |
| WO2005012484A2 (fr) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Conjugues anticorps-toxines |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US7956032B2 (en) | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| JP5743368B2 (ja) | 2004-01-08 | 2015-07-01 | ラショファーム ゲーエムベーハー | ペプチドのｏ結合型グリコシル化 |
| US20080300173A1 (en) | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
| WO2006031811A2 (fr) | 2004-09-10 | 2006-03-23 | Neose Technologies, Inc. | Interferon alpha glycopegyle |
| ES2566670T3 (es) | 2004-10-29 | 2016-04-14 | Ratiopharm Gmbh | Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF) |
| AU2006203792B2 (en) | 2005-01-10 | 2011-11-03 | Ratiopharm Gmbh | Glycopegylated Granulocyte Colony Stimulating Factor |
| EP1871795A4 (fr) | 2005-04-08 | 2010-03-31 | Biogenerix Ag | Compositions et méthodes utilisées pour la préparation de mutants par glycosylation de l'hormone de croissance humaine résistant à la protéase |
| WO2006127910A2 (fr) | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Formulations d'erythropoietine glycopegylees |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| WO2007056191A2 (fr) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Purification de sucre de nucleotide en utilisant des membranes |
| JP2009544327A (ja) | 2006-07-21 | 2009-12-17 | ノヴォ ノルディスク アー／エス | Ｏ−結合型グリコシル化配列によるペプチドのグリコシル化 |
| WO2008057683A2 (fr) | 2006-10-03 | 2008-05-15 | Novo Nordisk A/S | Méthodes de purification de conjugués de polypeptides |
| RS52845B (en) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF |
| US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
| US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
| RU2573587C2 (ru) | 2008-02-27 | 2016-01-20 | Ново Нордиск А/С | Конъюгированные молекулы фактора viii |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE56026B1 (en) * | 1982-10-19 | 1991-03-27 | Cetus Corp | Cysteine-depleted muteins of biologically active proteins |
-
1989
- 1989-12-11 EP EP19900901301 patent/EP0456642A1/fr not_active Withdrawn
- 1989-12-11 AU AU46631/89A patent/AU620673B2/en not_active Ceased
- 1989-12-11 JP JP50136890A patent/JP3207416B2/ja not_active Expired - Fee Related
- 1989-12-11 WO PCT/US1989/005445 patent/WO1990008823A1/fr not_active Application Discontinuation
- 1989-12-15 CA CA 2005502 patent/CA2005502C/fr not_active Expired - Fee Related
-
1991
- 1991-07-29 DK DK911404A patent/DK140491D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK140491A (da) | 1991-07-29 |
| CA2005502C (fr) | 2001-06-05 |
| AU620673B2 (en) | 1992-02-20 |
| DK140491D0 (da) | 1991-07-29 |
| AU4663189A (en) | 1990-08-24 |
| WO1990008823A1 (fr) | 1990-08-09 |
| JP3207416B2 (ja) | 2001-09-10 |
| EP0456642A1 (fr) | 1991-11-21 |
| JPH04503001A (ja) | 1992-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2005502A1 (fr) | Analogues de la somatotrophine | |
| CA2085750A1 (fr) | Formulations pharmaceutiques favorisant l'osteogenese | |
| GB8718777D0 (en) | Variants of bovine pancreatic trypsin inhibitor | |
| AUPP051497A0 (en) | Antimicrobial peptides | |
| DE69529219D1 (en) | Helicobacter proteine und impstoffe | |
| WO1989009787A3 (fr) | Dispositifs osteogeniques | |
| EP1333035A3 (fr) | Facteur GDF-8 de différentiation de croissance | |
| NZ503850A (en) | April - a novel protein with growth effects | |
| FI91160B (fi) | Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi | |
| HUT68021A (en) | Improved activating process of recombinant proteins | |
| CA2287521A1 (fr) | Beta-interferon recombinant humain ayant une meilleure solubilite | |
| GB9606040D0 (en) | Active peptide | |
| DE3572303D1 (en) | Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them | |
| EP0161007A3 (fr) | Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P | |
| IE902388L (en) | Vasoactive intestinal peptide analogs. | |
| AU634280B2 (en) | Anticoagulant peptides | |
| CS335390A3 (en) | Nonionic contrast means and process for preparing thereof | |
| EP0384731A3 (fr) | Facteurs de croissance ostéogéniques identifiés à partir de moelle osseuse régénératrice | |
| GB8906156D0 (en) | Production and use of anthelmintic agents and protective immunogens | |
| DK450187D0 (da) | Fremgangsmaade til fremstilling af proteiner | |
| HU896448D0 (en) | Process for the preparation of anticoagulant peptides | |
| DE59108261D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| GB2207132B (en) | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines | |
| DE69613489D1 (de) | Antibiotische peptide aus der kuhmilch | |
| IE950766L (en) | Protein protease inhibitors from streptomyces |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |